Home › Companies › ROYALTY PHARMA PLC › 2024-2025

ROYALTY PHARMA PLC 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and ROYALTY PHARMA PLC’s Form 8-K (Item 5.07 on EDGAR). Page generated 04 October 2026.

39Reported items
441Asset managers
11,048Fund votes
2025-05-12Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore ROYALTY PHARMA PLC in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by ROYALTY PHARMA PLC

These tallies are ROYALTY PHARMA PLC’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

ROYALTY PHARMA PLC — official shareholder meeting results, meeting held 2025-05-12
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Internalization Proposal	429,870,979	10,759,799	119,406	--	52,966,444	Majority: yes
Proposal 3. To approve, on a non-binding advisory basis, the compensation that may become payable to the Company's named executive officers in connection with the Transaction:	420,544,944	20,056,306	148,934	--	52,966,444	Majority: yes
Proposal 4. To adopt the 2025 Equity Incentive Plan:	421,957,432	18,098,447	694,305	--	52,966,444	Majority: yes
Proposal 5. To approve the terms of the agreements and counterparties pursuant to which the Company may purchase its Class A ordinary shares:	427,171,598	12,769,237	809,349	--	52,966,444	Majority: yes
Elect Director: Pablo Legorreta	418,582,710	22,097,928	69,546	--	52,966,444	Majority: yes
Elect Director: Henry Fernandez	436,765,409	3,917,789	66,986	--	52,966,444	Majority: yes
Elect Director: Bonnie Bassler, Ph.D.	435,725,056	4,959,621	65,507	--	52,966,444	Majority: yes
Elect Director: Vlad Coric, M.D.	438,209,798	2,473,998	66,388	--	52,966,444	Majority: yes
Elect Director: Errol De Souza, Ph.D.	431,649,202	9,034,000	66,982	--	52,966,444	Majority: yes
Elect Director: Catherine Engelbert	437,305,929	3,379,451	64,804	--	52,966,444	Majority: yes
Elect Director: David Hodgson	430,015,002	10,669,269	65,913	--	52,966,444	Majority: yes
Elect Director: Ted Love, M.D.	408,610,518	31,393,111	746,555	--	52,966,444	Majority: yes
Elect Director: Gregory Norden	429,848,858	10,832,657	68,669	--	52,966,444	Majority: yes
Proposal 7. To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers:	403,157,465	36,842,162	750,557	--	52,966,444	Majority: yes
Proposal 8. To ratify the appointment of Ernst & Young LLP, as the Company's independent registered public accounting firm:	493,521,988	116,396	78,244	--	--	Majority: yes
Proposal 11. To approve, on a non-binding advisory basis, the Company's U.K. directors' remuneration report in the U.K. Annual Report and Accounts:	400,460,685	40,156,539	132,960	--	52,966,444	Majority: yes
There were no broker non-votes on this proposal. Proposal 13. To authorize the Board of Directors to determine the remuneration of the Company's U.K. statutory auditor:	439,898,126	775,671	76,387	--	52,966,444	Majority: yes
Proposal 14. To authorize the Board of Directors to allot shares:	422,290,988	17,779,779	679,417	--	52,966,444	Majority: yes
Proposal 15. To authorize the Board of Directors to allot shares without rights of pre-emption:	406,273,297	33,785,707	691,180	--	52,966,444	Majority: yes

Source: ROYALTY PHARMA PLC, Form 8-K — read the filing on EDGAR.

How asset managers voted at the ROYALTY PHARMA PLC 2024-2025 meeting

Each item below shows how the 441 asset managers that disclosed a ROYALTY PHARMA PLC vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ROYALTY PHARMA PLC’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. A non-binding advisory vote to approve executive compensation that may become payable in connection with the transaction contemplated by the Membership Interest Purchase Agreement.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 420,544,944AGAINST: 20,056,306

ROYALTY PHARMA PLC’s own tally for this item (“Proposal 3. To approve, on a non-binding advisory basis, the compensation that may become payable to the Company's named executive officers in connection with the Transaction:”): 420,544,944 for, 20,056,306 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 418 asset managers below cast 94% of the shares they voted on this item FOR (303,452,144 for, 19,274,818 against).

FOR 94%

FOR: 303,452,144 (94.0%)AGAINST: 19,274,818 (6.0%)ABSTAIN: 90,519 (0.0%)NOT VOTED: 15,548 (0.0%)

Largest asset managers voting on “A non-binding advisory vote to approve executive compensation that may become payable in connection with the t” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Vote
Fidelity	68,011,243	0	0	For
Morgan Stanley	42,544,868	0	0	For
Vanguard	38,679,460	7	0	For
BlackRock	18,111,737	533,989	0	For
Swedbank Robur Fonder AB	0	12,157,470	0	Against
Victory Capital	10,082,091	0	0	For
VIKING GLOBAL INVESTORS LP	9,005,924	0	0	For
GEODE CAPITAL MANAGEMENT, LLC	8,037,857	0	0	For
State Street	7,347,102	0	0	For
Charles Schwab	6,273,956	0	0	For
Capital Group	4,846,908	0	0	For
Caledonia (Private) Investments Pty Ltd	4,436,080	0	0	For
BAILLIE GIFFORD & CO LTD	3,736,525	0	0	For
BAILLIE GIFFORD OVERSEAS LTD	3,337,823	0	0	For
BAILLIE GIFFORD & CO	2,773,581	0	0	For
NEW SOUTH CAPITAL MANAGEMENT INC	2,661,054	0	0	For
Transamerica	2,430,209	0	0	For
GMT CAPITAL CORP	2,335,427	0	0	For
Northern Trust	2,279,114	0	0	For
Advisor Managed Portfolios	2,270,000	0	0	For
Legal & General Investment Management Ltd	104,536	2,057,839	0	Against
Brighthouse	1,979,775	0	40,943	For
HOMESTEAD ADVISERS CORP	1,939,440	0	0	For
AQR	1,930,926	0	0	For
PARAMETRIC PORTFOLIO ASSOCIATES LLC	1,830,648	0	0	For

Showing the 25 largest of 418 asset managers. See all 418 in the interactive database.

2. A non-binding advisory vote to approve executive compensation.

SECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

89% fund support · no official result

FOR 89%11%

The 414 asset managers below cast 89% of the shares they voted on this item FOR (288,209,716 for, 34,499,061 against).

FOR: 288,209,716 (89.3%)AGAINST: 34,499,061 (10.7%)ABSTAIN: 100,020 (0.0%)NOT VOTED: 15,548 (0.0%)

Largest asset managers voting on “A non-binding advisory vote to approve executive compensation.” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Vote
Fidelity	68,011,243	0	0	For
Morgan Stanley	42,544,868	0	0	For
Vanguard	38,664,311	15,156	1	For
BlackRock	18,644,447	1,279	0	For
Swedbank Robur Fonder AB	0	12,157,470	0	Against
Victory Capital	10,082,091	0	0	For
VIKING GLOBAL INVESTORS LP	9,005,924	0	0	For
GEODE CAPITAL MANAGEMENT, LLC	8,037,857	0	0	For
State Street	7,347,102	0	0	For
Charles Schwab	6,273,956	0	0	For
Capital Group	4,846,908	0	0	For
Caledonia (Private) Investments Pty Ltd	4,436,080	0	0	For
BAILLIE GIFFORD & CO LTD	3,736,525	0	0	For
BAILLIE GIFFORD OVERSEAS LTD	3,337,823	0	0	For
BAILLIE GIFFORD & CO	2,773,581	0	0	For
NEW SOUTH CAPITAL MANAGEMENT INC	2,661,054	0	0	For
Transamerica	2,430,209	0	0	For
GMT CAPITAL CORP	0	2,335,427	0	Against
Northern Trust	2,279,114	0	0	For
Advisor Managed Portfolios	2,270,000	0	0	For
Legal & General Investment Management Ltd	2,156,061	6,314	0	For
Brighthouse	1,979,775	0	40,943	For
HOMESTEAD ADVISERS CORP	1,939,440	0	0	For
AQR	1,930,926	0	0	For
PARAMETRIC PORTFOLIO ASSOCIATES LLC	1,830,648	0	0	For

Showing the 25 largest of 414 asset managers. See all 414 in the interactive database.

3. Approve on a non-binding advisory basis our U.K. directors' remuneration report (other than the part containing the directors' remuneration policy) for the fiscal year ended December 31, 2024.

SECTION 14A SAY-ON-PAY VOTES

Combines 6 wordings of this item as funds reported it.

95% fund support · no official result

FOR 95%

The 114 asset managers below cast 95% of the shares they voted on this item FOR (134,061,968 for, 7,100,793 against).

FOR: 134,061,968 (94.9%)AGAINST: 7,100,793 (5.0%)ABSTAIN: 40,943 (0.0%)NOT VOTED: 151 (0.0%)

Largest asset managers voting on “Approve on a non-binding advisory basis our U.K. directors' remuneration report (other than the part containin” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	36,879,379	15,160	0	For
Fidelity	36,506,273	0	0	For
BlackRock	18,644,447	1,279	0	For
Morgan Stanley	10,461,310	0	0	For
Victory Capital	6,381,179	0	0	For
Caledonia (Private) Investments Pty Ltd	4,436,080	0	0	For
Charles Schwab	775	3,108,692	0	Against
Transamerica	2,430,209	0	0	For
Advisor Managed Portfolios	2,270,000	0	0	For
Brighthouse	1,979,775	0	40,943	For
Capital Group	1,912,455	0	0	For
First Trust	1,026,416	0	0	For
TIAA	837,390	0	0	For
Waddell & Reed	799,720	0	0	For
MUTUAL FUND SERIES TRUST	785,423	0	0	For
SEI	0	778,152	0	Against
Dimensional	0	757,205	0	Against
INVESTMENT CO OF AMERICA	746,548	0	0	For
Russell Investments	0	706,504	0	Against
WEDGE CAPITAL MANAGEMENT L L P/NC	30,845	625,497	0	Against
Pacific Life	597,826	0	0	For
AQR	589,521	0	0	For
Invesco	492,262	0	0	For
HOMESTEAD FUNDS INC	483,484	0	0	For
Thrivent	464,381	0	0	For

Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.

4. APPROVE THE ADOPTION THE 2025 EQUITY INCENTIVE PLAN.

COMPENSATIONMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 421,957,432AGAINST: 18,098,447

ROYALTY PHARMA PLC’s own tally for this item (“Proposal 4. To adopt the 2025 Equity Incentive Plan:”): 421,957,432 for, 18,098,447 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 97 asset managers below cast 99.9% of the shares they voted on this item FOR (128,011,496 for, 75,932 against).

FOR 99.9%

FOR: 128,011,496 (99.9%)AGAINST: 75,932 (0.1%)ABSTAIN: 1 (0.0%)NOT VOTED: 151 (0.0%)

Largest asset managers voting on “APPROVE THE ADOPTION THE 2025 EQUITY INCENTIVE PLAN.” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	36,894,533	5	1	For
Fidelity	36,506,273	0	0	For
Morgan Stanley	10,461,310	0	0	For
BlackRock	6,959,499	0	0	For
Victory Capital	6,381,179	0	0	For
Caledonia (Private) Investments Pty Ltd	4,436,080	0	0	For
Charles Schwab	3,109,467	0	0	For
Transamerica	2,430,209	0	0	For
Advisor Managed Portfolios	2,270,000	0	0	For
Brighthouse	2,020,718	0	0	For
Capital Group	1,912,455	0	0	For
First Trust	1,013,486	0	0	For
TIAA	837,390	0	0	For
Waddell & Reed	799,720	0	0	For
MUTUAL FUND SERIES TRUST	785,423	0	0	For
SEI	778,152	0	0	For
Dimensional	757,205	0	0	For
INVESTMENT CO OF AMERICA	746,548	0	0	For
Russell Investments	706,504	0	0	For
Pacific Life	597,826	0	0	For
AQR	589,521	0	0	For
Invesco	492,262	0	0	For
HOMESTEAD FUNDS INC	483,484	0	0	For
Thrivent	464,381	0	0	For
JPMorgan	451,921	0	0	For

Showing the 25 largest of 97 asset managers. See all 97 in the interactive database.

5. APPROVE ON A BINDING BASIS OUR U.K. DIRECTORS' REMUNERATION POLICY.

COMPENSATION

Combines 3 wordings of this item as funds reported it.

96% fund support · no official result

FOR 96%

The 96 asset managers below cast 96% of the shares they voted on this item FOR (133,570,035 for, 6,167,908 against).

FOR: 133,570,035 (95.6%)AGAINST: 6,167,908 (4.4%)ABSTAIN: 40,944 (0.0%)NOT VOTED: 151 (0.0%)

Largest asset managers voting on “APPROVE ON A BINDING BASIS OUR U.K. DIRECTORS' REMUNERATION POLICY.” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	36,879,377	15,161	1	For
Fidelity	36,506,273	0	0	For
BlackRock	18,644,447	1,279	0	For
Morgan Stanley	10,461,310	0	0	For
Victory Capital	6,381,179	0	0	For
Caledonia (Private) Investments Pty Ltd	4,436,080	0	0	For
Charles Schwab	775	3,108,692	0	Against
Transamerica	2,430,209	0	0	For
Advisor Managed Portfolios	2,270,000	0	0	For
Brighthouse	1,979,775	0	40,943	For
Capital Group	1,912,455	0	0	For
First Trust	1,013,486	0	0	For
TIAA	837,390	0	0	For
Waddell & Reed	799,720	0	0	For
MUTUAL FUND SERIES TRUST	785,423	0	0	For
SEI	0	778,152	0	Against
Dimensional	0	757,205	0	Against
INVESTMENT CO OF AMERICA	746,548	0	0	For
Russell Investments	0	706,504	0	Against
Pacific Life	597,826	0	0	For
AQR	589,521	0	0	For
Invesco	492,262	0	0	For
HOMESTEAD FUNDS INC	483,484	0	0	For
Thrivent	464,381	0	0	For
JPMorgan	451,921	0	0	For

Showing the 25 largest of 96 asset managers. See all 96 in the interactive database.

6. RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 493,521,988AGAINST: 116,396

ROYALTY PHARMA PLC’s own tally for this item (“Proposal 8. To ratify the appointment of Ernst & Young LLP, as the Company's independent registered public accounting firm:”): 493,521,988 for, 116,396 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 96 asset managers below cast 99.9% of the shares they voted on this item FOR (123,671,037 for, 0 against).

FOR 99.9%

FOR: 123,671,037 (100.0%)AGAINST: 0 (0.0%)ABSTAIN: 40,943 (0.0%)NOT VOTED: 151 (0.0%)

Largest asset managers voting on “RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	36,894,539	0	For
Fidelity	36,506,273	0	For
Morgan Stanley	10,461,310	0	For
BlackRock	6,959,499	0	For
Victory Capital	6,381,179	0	For
Charles Schwab	3,109,467	0	For
Transamerica	2,430,209	0	For
Advisor Managed Portfolios	2,270,000	0	For
Brighthouse	1,979,775	40,943	For
Capital Group	1,912,455	0	For
First Trust	1,013,486	0	For
TIAA	837,390	0	For
Waddell & Reed	799,720	0	For
MUTUAL FUND SERIES TRUST	785,423	0	For
SEI	778,152	0	For
Dimensional	757,205	0	For
INVESTMENT CO OF AMERICA	746,548	0	For
Russell Investments	706,504	0	For
Pacific Life	597,826	0	For
AQR	589,521	0	For
Invesco	492,262	0	For
HOMESTEAD FUNDS INC	483,484	0	For
Thrivent	464,381	0	For
JPMorgan	451,921	0	For
AB EQUITY INCOME FUND INC	365,672	0	For

Showing the 25 largest of 96 asset managers. See all 96 in the interactive database.

7. AUTHORIZE THE BOARD TO DETERMINE THE REMUNERATION OF ERNST & YOUNG IN ITS CAPACITY AS OUR U.K. STATUTORY AUDITOR.

COMPENSATIONMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%

FOR: 439,898,126AGAINST: 775,671

ROYALTY PHARMA PLC’s own tally for this item (“There were no broker non-votes on this proposal. Proposal 13. To authorize the Board of Directors to determine the remuneration of the Company's U.K. statutory auditor:”): 439,898,126 for, 775,671 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 96 asset managers below cast 99.9% of the shares they voted on this item FOR (123,671,119 for, 1 against).

FOR 99.9%

FOR: 123,671,119 (100.0%)AGAINST: 1 (0.0%)ABSTAIN: 40,943 (0.0%)NOT VOTED: 151 (0.0%)

Largest asset managers voting on “AUTHORIZE THE BOARD TO DETERMINE THE REMUNERATION OF ERNST & YOUNG IN ITS CAPACITY AS OUR U.K. STATUTORY AUDIT” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	36,894,538	1	0	For
Fidelity	36,506,273	0	0	For
Morgan Stanley	10,461,310	0	0	For
BlackRock	6,959,499	0	0	For
Victory Capital	6,381,179	0	0	For
Charles Schwab	3,109,467	0	0	For
Transamerica	2,430,209	0	0	For
Advisor Managed Portfolios	2,270,000	0	0	For
Brighthouse	1,979,775	0	40,943	For
Capital Group	1,912,455	0	0	For
First Trust	1,013,486	0	0	For
TIAA	837,390	0	0	For
Waddell & Reed	799,720	0	0	For
MUTUAL FUND SERIES TRUST	785,423	0	0	For
SEI	778,152	0	0	For
Dimensional	757,205	0	0	For
INVESTMENT CO OF AMERICA	746,548	0	0	For
Russell Investments	706,504	0	0	For
Pacific Life	597,826	0	0	For
AQR	589,521	0	0	For
Invesco	492,262	0	0	For
HOMESTEAD FUNDS INC	483,484	0	0	For
Thrivent	464,381	0	0	For
JPMorgan	451,921	0	0	For
AB EQUITY INCOME FUND INC	365,672	0	0	For

Showing the 25 largest of 96 asset managers. See all 96 in the interactive database.

8. Election of Directors: Bonnie Bassler, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 435,725,056AGAINST: 4,959,621

ROYALTY PHARMA PLC’s own tally for this item (“Elect Director: Bonnie Bassler, Ph.D.”): 435,725,056 for, 4,959,621 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 95 asset managers below cast 99.2% of the shares they voted on this item FOR (122,745,886 for, 925,134 against).

FOR 99.2%

FOR: 122,745,886 (99.2%)AGAINST: 925,134 (0.7%)ABSTAIN: 40,943 (0.0%)NOT VOTED: 151 (0.0%)

Largest asset managers voting on “Election of Directors: Bonnie Bassler, Ph.D.” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	36,894,535	4	0	For
Fidelity	36,506,273	0	0	For
Morgan Stanley	10,461,310	0	0	For
BlackRock	6,959,499	0	0	For
Victory Capital	6,381,179	0	0	For
Charles Schwab	3,109,467	0	0	For
Transamerica	2,430,209	0	0	For
Advisor Managed Portfolios	2,270,000	0	0	For
Brighthouse	1,979,775	0	40,943	For
Capital Group	1,912,455	0	0	For
First Trust	1,013,486	0	0	For
TIAA	837,390	0	0	For
Waddell & Reed	799,720	0	0	For
MUTUAL FUND SERIES TRUST	785,423	0	0	For
SEI	778,152	0	0	For
Dimensional	0	757,205	0	Against
INVESTMENT CO OF AMERICA	746,548	0	0	For
Russell Investments	706,504	0	0	For
Pacific Life	597,826	0	0	For
AQR	589,521	0	0	For
Invesco	492,262	0	0	For
HOMESTEAD FUNDS INC	483,484	0	0	For
Thrivent	464,381	0	0	For
JPMorgan	451,921	0	0	For
AB EQUITY INCOME FUND INC	365,672	0	0	For

Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.

9. Election of Directors: Catherine Engelbert

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%

FOR: 437,305,929AGAINST: 3,379,451

ROYALTY PHARMA PLC’s own tally for this item (“Elect Director: Catherine Engelbert”): 437,305,929 for, 3,379,451 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 95 asset managers below cast 99.9% of the shares they voted on this item FOR (123,609,033 for, 61,987 against).

FOR 99.9%

FOR: 123,609,033 (99.9%)AGAINST: 61,987 (0.1%)ABSTAIN: 40,943 (0.0%)NOT VOTED: 151 (0.0%)

Largest asset managers voting on “Election of Directors: Catherine Engelbert” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	36,894,536	3	0	For
Fidelity	36,506,273	0	0	For
Morgan Stanley	10,461,310	0	0	For
BlackRock	6,959,499	0	0	For
Victory Capital	6,381,179	0	0	For
Charles Schwab	3,109,467	0	0	For
Transamerica	2,430,209	0	0	For
Advisor Managed Portfolios	2,270,000	0	0	For
Brighthouse	1,979,775	0	40,943	For
Capital Group	1,912,455	0	0	For
First Trust	1,013,486	0	0	For
TIAA	837,390	0	0	For
Waddell & Reed	799,720	0	0	For
MUTUAL FUND SERIES TRUST	785,423	0	0	For
SEI	778,152	0	0	For
Dimensional	757,205	0	0	For
INVESTMENT CO OF AMERICA	746,548	0	0	For
Russell Investments	706,504	0	0	For
Pacific Life	597,826	0	0	For
AQR	589,521	0	0	For
Invesco	492,262	0	0	For
HOMESTEAD FUNDS INC	483,484	0	0	For
Thrivent	464,381	0	0	For
JPMorgan	451,921	0	0	For
AB EQUITY INCOME FUND INC	365,672	0	0	For

Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.

10. Election of Directors: David Hodgson

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 430,015,002AGAINST: 10,669,269

ROYALTY PHARMA PLC’s own tally for this item (“Elect Director: David Hodgson”): 430,015,002 for, 10,669,269 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 95 asset managers below cast 99.2% of the shares they voted on this item FOR (122,724,925 for, 946,095 against).

FOR 99.2%

FOR: 122,724,925 (99.2%)AGAINST: 946,095 (0.8%)ABSTAIN: 40,943 (0.0%)NOT VOTED: 151 (0.0%)

Largest asset managers voting on “Election of Directors: David Hodgson” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	36,894,531	8	0	For
Fidelity	36,506,273	0	0	For
Morgan Stanley	10,461,310	0	0	For
BlackRock	6,959,499	0	0	For
Victory Capital	6,381,179	0	0	For
Charles Schwab	3,109,467	0	0	For
Transamerica	2,430,209	0	0	For
Advisor Managed Portfolios	2,270,000	0	0	For
Brighthouse	1,979,775	0	40,943	For
Capital Group	1,912,455	0	0	For
First Trust	1,013,486	0	0	For
TIAA	837,390	0	0	For
Waddell & Reed	799,720	0	0	For
MUTUAL FUND SERIES TRUST	785,423	0	0	For
SEI	778,152	0	0	For
Dimensional	0	757,205	0	Against
INVESTMENT CO OF AMERICA	746,548	0	0	For
Russell Investments	706,504	0	0	For
Pacific Life	597,826	0	0	For
AQR	589,521	0	0	For
Invesco	492,262	0	0	For
HOMESTEAD FUNDS INC	483,484	0	0	For
Thrivent	464,381	0	0	For
JPMorgan	451,921	0	0	For
AB EQUITY INCOME FUND INC	365,672	0	0	For

Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.

11. Election of Directors: Errol De Souza, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 431,649,202AGAINST: 9,034,000

ROYALTY PHARMA PLC’s own tally for this item (“Elect Director: Errol De Souza, Ph.D.”): 431,649,202 for, 9,034,000 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 95 asset managers below cast 99.2% of the shares they voted on this item FOR (122,720,949 for, 950,071 against).

FOR 99.1%

FOR: 122,720,949 (99.2%)AGAINST: 950,071 (0.8%)ABSTAIN: 40,943 (0.0%)NOT VOTED: 151 (0.0%)

Largest asset managers voting on “Election of Directors: Errol De Souza, Ph.D.” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	36,894,530	8	0	For
Fidelity	36,506,273	0	0	For
Morgan Stanley	10,461,310	0	0	For
BlackRock	6,959,499	0	0	For
Victory Capital	6,381,179	0	0	For
Charles Schwab	3,109,467	0	0	For
Transamerica	2,430,209	0	0	For
Advisor Managed Portfolios	2,270,000	0	0	For
Brighthouse	1,979,775	0	40,943	For
Capital Group	1,912,455	0	0	For
First Trust	1,013,486	0	0	For
TIAA	837,390	0	0	For
Waddell & Reed	799,720	0	0	For
MUTUAL FUND SERIES TRUST	785,423	0	0	For
SEI	774,176	3,976	0	For
Dimensional	0	757,205	0	Against
INVESTMENT CO OF AMERICA	746,548	0	0	For
Russell Investments	706,504	0	0	For
Pacific Life	597,826	0	0	For
AQR	589,521	0	0	For
Invesco	492,262	0	0	For
HOMESTEAD FUNDS INC	483,484	0	0	For
Thrivent	464,381	0	0	For
JPMorgan	451,921	0	0	For
AB EQUITY INCOME FUND INC	365,672	0	0	For

Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.

12. Election of Directors: Gregory Norden

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 429,848,858AGAINST: 10,832,657

ROYALTY PHARMA PLC’s own tally for this item (“Elect Director: Gregory Norden”): 429,848,858 for, 10,832,657 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 95 asset managers below cast 99.2% of the shares they voted on this item FOR (122,725,020 for, 946,001 against).

FOR 99.2%

FOR: 122,725,020 (99.2%)AGAINST: 946,001 (0.8%)ABSTAIN: 40,943 (0.0%)NOT VOTED: 151 (0.0%)

Largest asset managers voting on “Election of Directors: Gregory Norden” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	36,894,530	9	0	For
Fidelity	36,506,273	0	0	For
Morgan Stanley	10,461,310	0	0	For
BlackRock	6,959,499	0	0	For
Victory Capital	6,381,179	0	0	For
Charles Schwab	3,109,467	0	0	For
Transamerica	2,430,209	0	0	For
Advisor Managed Portfolios	2,270,000	0	0	For
Brighthouse	1,979,775	0	40,943	For
Capital Group	1,912,455	0	0	For
First Trust	1,013,486	0	0	For
TIAA	837,390	0	0	For
Waddell & Reed	799,720	0	0	For
MUTUAL FUND SERIES TRUST	785,423	0	0	For
SEI	774,176	3,976	0	For
Dimensional	0	757,205	0	Against
INVESTMENT CO OF AMERICA	746,548	0	0	For
Russell Investments	706,504	0	0	For
Pacific Life	597,826	0	0	For
AQR	589,521	0	0	For
Invesco	492,262	0	0	For
HOMESTEAD FUNDS INC	483,484	0	0	For
Thrivent	464,381	0	0	For
JPMorgan	451,921	0	0	For
AB EQUITY INCOME FUND INC	365,672	0	0	For

Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.

13. Election of Directors: Henry Fernandez

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%

FOR: 436,765,409AGAINST: 3,917,789

ROYALTY PHARMA PLC’s own tally for this item (“Elect Director: Henry Fernandez”): 436,765,409 for, 3,917,789 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 95 asset managers below cast 99.9% of the shares they voted on this item FOR (123,629,991 for, 41,030 against).

FOR 99.9%

FOR: 123,629,991 (99.9%)AGAINST: 41,030 (0.0%)ABSTAIN: 40,943 (0.0%)NOT VOTED: 151 (0.0%)

Largest asset managers voting on “Election of Directors: Henry Fernandez” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	36,894,536	3	0	For
Fidelity	36,506,273	0	0	For
Morgan Stanley	10,461,310	0	0	For
BlackRock	6,959,499	0	0	For
Victory Capital	6,381,179	0	0	For
Charles Schwab	3,109,467	0	0	For
Transamerica	2,430,209	0	0	For
Advisor Managed Portfolios	2,270,000	0	0	For
Brighthouse	1,979,775	0	40,943	For
Capital Group	1,912,455	0	0	For
First Trust	1,013,486	0	0	For
TIAA	837,390	0	0	For
Waddell & Reed	799,720	0	0	For
MUTUAL FUND SERIES TRUST	785,423	0	0	For
SEI	778,152	0	0	For
Dimensional	757,205	0	0	For
INVESTMENT CO OF AMERICA	746,548	0	0	For
Russell Investments	706,504	0	0	For
Pacific Life	597,826	0	0	For
AQR	589,521	0	0	For
Invesco	492,262	0	0	For
HOMESTEAD FUNDS INC	483,484	0	0	For
Thrivent	464,381	0	0	For
JPMorgan	451,921	0	0	For
AB EQUITY INCOME FUND INC	365,672	0	0	For

Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.

14. Election of Directors: Pablo Legorreta

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 418,582,710AGAINST: 22,097,928

ROYALTY PHARMA PLC’s own tally for this item (“Elect Director: Pablo Legorreta”): 418,582,710 for, 22,097,928 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 95 asset managers below cast 99.8% of the shares they voted on this item FOR (123,471,998 for, 199,023 against).

FOR 99.8%

FOR: 123,471,998 (99.8%)AGAINST: 199,023 (0.2%)ABSTAIN: 40,943 (0.0%)NOT VOTED: 151 (0.0%)

Largest asset managers voting on “Election of Directors: Pablo Legorreta” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	36,894,530	9	0	For
Fidelity	36,506,273	0	0	For
Morgan Stanley	10,461,310	0	0	For
BlackRock	6,959,499	0	0	For
Victory Capital	6,381,179	0	0	For
Charles Schwab	3,109,467	0	0	For
Transamerica	2,430,209	0	0	For
Advisor Managed Portfolios	2,270,000	0	0	For
Brighthouse	1,979,775	0	40,943	For
Capital Group	1,912,455	0	0	For
First Trust	1,013,486	0	0	For
TIAA	837,390	0	0	For
Waddell & Reed	799,720	0	0	For
MUTUAL FUND SERIES TRUST	785,423	0	0	For
SEI	778,152	0	0	For
Dimensional	697,319	59,886	0	For
INVESTMENT CO OF AMERICA	746,548	0	0	For
Russell Investments	706,504	0	0	For
Pacific Life	597,826	0	0	For
AQR	589,521	0	0	For
Invesco	492,262	0	0	For
HOMESTEAD FUNDS INC	483,484	0	0	For
Thrivent	464,381	0	0	For
JPMorgan	451,921	0	0	For
AB EQUITY INCOME FUND INC	365,672	0	0	For

Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.

15. Election of Directors: Ted Love, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%7%

FOR: 408,610,518AGAINST: 31,393,111

ROYALTY PHARMA PLC’s own tally for this item (“Elect Director: Ted Love, M.D.”): 408,610,518 for, 31,393,111 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 95 asset managers below cast 97% of the shares they voted on this item FOR (120,399,846 for, 3,173,553 against).

FOR 97%

FOR: 120,399,846 (97.3%)AGAINST: 3,173,553 (2.6%)ABSTAIN: 138,565 (0.1%)NOT VOTED: 151 (0.0%)

Largest asset managers voting on “Election of Directors: Ted Love, M.D.” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	36,887,672	6,866	1	For
Fidelity	36,506,273	0	0	For
Morgan Stanley	10,454,301	7,009	0	For
BlackRock	6,959,499	0	0	For
Victory Capital	6,381,179	0	0	For
Charles Schwab	3,109,467	0	0	For
Transamerica	2,430,209	0	0	For
Advisor Managed Portfolios	2,270,000	0	0	For
Brighthouse	1,979,775	0	40,943	For
Capital Group	1,912,455	0	0	For
First Trust	1,013,486	0	0	For
TIAA	837,390	0	0	For
Waddell & Reed	0	799,720	0	Against
MUTUAL FUND SERIES TRUST	785,423	0	0	For
SEI	0	778,152	0	Against
Dimensional	757,205	0	0	For
INVESTMENT CO OF AMERICA	746,548	0	0	For
Russell Investments	0	706,504	0	Against
Pacific Life	597,826	0	0	For
AQR	589,521	0	0	For
Invesco	492,262	0	0	For
HOMESTEAD FUNDS INC	483,484	0	0	For
Thrivent	464,381	0	0	For
JPMorgan	451,921	0	0	For
AB EQUITY INCOME FUND INC	365,672	0	0	For

Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.

16. Election of Directors: Vlad Coric, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%

FOR: 438,209,798AGAINST: 2,473,998

ROYALTY PHARMA PLC’s own tally for this item (“Elect Director: Vlad Coric, M.D.”): 438,209,798 for, 2,473,998 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 95 asset managers below cast 99.9% of the shares they voted on this item FOR (123,671,019 for, 1 against).

FOR 99.9%

FOR: 123,671,019 (100.0%)AGAINST: 1 (0.0%)ABSTAIN: 40,943 (0.0%)NOT VOTED: 151 (0.0%)

Largest asset managers voting on “Election of Directors: Vlad Coric, M.D.” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	36,894,538	1	0	For
Fidelity	36,506,273	0	0	For
Morgan Stanley	10,461,310	0	0	For
BlackRock	6,959,499	0	0	For
Victory Capital	6,381,179	0	0	For
Charles Schwab	3,109,467	0	0	For
Transamerica	2,430,209	0	0	For
Advisor Managed Portfolios	2,270,000	0	0	For
Brighthouse	1,979,775	0	40,943	For
Capital Group	1,912,455	0	0	For
First Trust	1,013,486	0	0	For
TIAA	837,390	0	0	For
Waddell & Reed	799,720	0	0	For
MUTUAL FUND SERIES TRUST	785,423	0	0	For
SEI	778,152	0	0	For
Dimensional	757,205	0	0	For
INVESTMENT CO OF AMERICA	746,548	0	0	For
Russell Investments	706,504	0	0	For
Pacific Life	597,826	0	0	For
AQR	589,521	0	0	For
Invesco	492,262	0	0	For
HOMESTEAD FUNDS INC	483,484	0	0	For
Thrivent	464,381	0	0	For
JPMorgan	451,921	0	0	For
AB EQUITY INCOME FUND INC	365,672	0	0	For

Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.

17. APPROVE (A) THE MEMBERSHIP INTEREST PURCHASE AGREEMENT AND EACH OTHER TRANSACTION DOCUMENT, (B) GRANT ALLOTMENT AUTHORITY FOR THE ISSUANCE OF (I) ADDITIONAL CLASS A ORDINARY SHARES OF ROYALTY PHARMA PLC SUFFICIENT TO ALLOW FOR THE EXCHANGE OF A NUMBER OF CLASS B ORDINARY SHARES OF ROYALTY PHARMA HOLDINGS LTD. EQUAL TO THE SHARE CONSIDERATION AND (II) ADDITIONAL CLASS B ORDINARY SHARES OF ROYALTY P

CAPITAL STRUCTURE

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 94 asset managers below cast 99.9% of the shares they voted on this item FOR (123,651,231 for, 0 against).

FOR: 123,651,231 (100.0%)AGAINST: 0 (0.0%)ABSTAIN: 0 (0.0%)NOT VOTED: 151 (0.0%)

Largest asset managers voting on “APPROVE (A) THE MEMBERSHIP INTEREST PURCHASE AGREEMENT AND EACH OTHER TRANSACTION DOCUMENT, (B) GRANT ALLOTMEN” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Vote
Vanguard	36,894,539	For
Fidelity	36,506,273	For
Morgan Stanley	10,461,310	For
BlackRock	6,959,499	For
Victory Capital	6,381,179	For
Charles Schwab	3,109,467	For
Transamerica	2,430,209	For
Advisor Managed Portfolios	2,270,000	For
Brighthouse	2,020,718	For
Capital Group	1,912,455	For
First Trust	1,013,486	For
TIAA	837,390	For
Waddell & Reed	799,720	For
MUTUAL FUND SERIES TRUST	785,423	For
SEI	778,152	For
Dimensional	757,205	For
INVESTMENT CO OF AMERICA	746,548	For
Russell Investments	706,504	For
Pacific Life	597,826	For
AQR	589,521	For
Invesco	492,262	For
HOMESTEAD FUNDS INC	483,484	For
Thrivent	464,381	For
JPMorgan	451,921	For
AB EQUITY INCOME FUND INC	365,672	For

Showing the 25 largest of 94 asset managers. See all 94 in the interactive database.

18. APPROVE THE TERMS OF THE AGREEMENTS AND COUNTERPARTIES PURSUANT TO WHICH WE MAY PURCHASE OUR CLASS A ORDINARY SHARES.

EXTRAORDINARY TRANSACTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 427,171,598AGAINST: 12,769,237

ROYALTY PHARMA PLC’s own tally for this item (“Proposal 5. To approve the terms of the agreements and counterparties pursuant to which the Company may purchase its Class A ordinary shares:”): 427,171,598 for, 12,769,237 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 94 asset managers below cast 99.9% of the shares they voted on this item FOR (123,651,230 for, 1 against).

FOR 99.9%

FOR: 123,651,230 (100.0%)AGAINST: 1 (0.0%)ABSTAIN: 1 (0.0%)NOT VOTED: 151 (0.0%)

Largest asset managers voting on “APPROVE THE TERMS OF THE AGREEMENTS AND COUNTERPARTIES PURSUANT TO WHICH WE MAY PURCHASE OUR CLASS A ORDINARY ” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	36,894,537	1	1	For
Fidelity	36,506,273	0	0	For
Morgan Stanley	10,461,310	0	0	For
BlackRock	6,959,499	0	0	For
Victory Capital	6,381,179	0	0	For
Charles Schwab	3,109,467	0	0	For
Transamerica	2,430,209	0	0	For
Advisor Managed Portfolios	2,270,000	0	0	For
Brighthouse	2,020,718	0	0	For
Capital Group	1,912,455	0	0	For
First Trust	1,013,486	0	0	For
TIAA	837,390	0	0	For
Waddell & Reed	799,720	0	0	For
MUTUAL FUND SERIES TRUST	785,423	0	0	For
SEI	778,152	0	0	For
Dimensional	757,205	0	0	For
INVESTMENT CO OF AMERICA	746,548	0	0	For
Russell Investments	706,504	0	0	For
Pacific Life	597,826	0	0	For
AQR	589,521	0	0	For
Invesco	492,262	0	0	For
HOMESTEAD FUNDS INC	483,484	0	0	For
Thrivent	464,381	0	0	For
JPMorgan	451,921	0	0	For
AB EQUITY INCOME FUND INC	365,672	0	0	For

Showing the 25 largest of 94 asset managers. See all 94 in the interactive database.

19. APPROVE RECEIPT OF OUR U.K. AUDITED ANNUAL REPORT AND ACCOUNTS AND RELATED DIRECTORS' AND AUDITOR'S REPORTS FOR THE FISCAL YEAR ENDED DECEMBER 31, 2024.

AUDIT-RELATED

Combines 4 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 93 asset managers below cast 99.9% of the shares they voted on this item FOR (123,609,646 for, 0 against).

FOR: 123,609,646 (100.0%)AGAINST: 0 (0.0%)ABSTAIN: 40,944 (0.0%)NOT VOTED: 151 (0.0%)

Largest asset managers voting on “APPROVE RECEIPT OF OUR U.K. AUDITED ANNUAL REPORT AND ACCOUNTS AND RELATED DIRECTORS' AND AUDITOR'S REPORTS FO” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	36,894,538	1	For
Fidelity	36,506,273	0	For
Morgan Stanley	10,461,310	0	For
BlackRock	6,959,499	0	For
Victory Capital	6,381,179	0	For
Charles Schwab	3,109,467	0	For
Transamerica	2,430,209	0	For
Advisor Managed Portfolios	2,270,000	0	For
Brighthouse	1,979,775	40,943	For
Capital Group	1,912,455	0	For
First Trust	1,013,486	0	For
TIAA	837,390	0	For
Waddell & Reed	799,720	0	For
MUTUAL FUND SERIES TRUST	785,423	0	For
SEI	778,152	0	For
Dimensional	757,205	0	For
INVESTMENT CO OF AMERICA	746,548	0	For
Russell Investments	706,504	0	For
Pacific Life	597,826	0	For
AQR	589,521	0	For
Invesco	492,262	0	For
HOMESTEAD FUNDS INC	483,484	0	For
Thrivent	464,381	0	For
JPMorgan	451,921	0	For
AB EQUITY INCOME FUND INC	365,672	0	For

Showing the 25 largest of 93 asset managers. See all 93 in the interactive database.

20. AUTHORIZE THE BOARD TO ALLOT SHARES WITHOUT RIGHTS OF PRE-EMPTION (SPECIAL RESOLUTION).

SHAREHOLDER RIGHTS AND DEFENSESMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%8%

FOR: 406,273,297AGAINST: 33,785,707

ROYALTY PHARMA PLC’s own tally for this item (“Proposal 15. To authorize the Board of Directors to allot shares without rights of pre-emption:”): 406,273,297 for, 33,785,707 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 93 asset managers below cast 99% of the shares they voted on this item FOR (122,046,001 for, 1,604,587 against).

FOR 99%

FOR: 122,046,001 (98.7%)AGAINST: 1,604,587 (1.3%)ABSTAIN: 1 (0.0%)NOT VOTED: 151 (0.0%)

Largest asset managers voting on “AUTHORIZE THE BOARD TO ALLOT SHARES WITHOUT RIGHTS OF PRE-EMPTION (SPECIAL RESOLUTION).” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	35,609,077	1,285,461	1	For
Fidelity	36,506,273	0	0	For
Morgan Stanley	10,461,310	0	0	For
BlackRock	6,959,499	0	0	For
Victory Capital	6,381,179	0	0	For
Charles Schwab	3,109,467	0	0	For
Transamerica	2,430,209	0	0	For
Advisor Managed Portfolios	2,270,000	0	0	For
Brighthouse	1,979,775	40,943	0	For
Capital Group	1,912,455	0	0	For
First Trust	1,013,486	0	0	For
TIAA	837,390	0	0	For
Waddell & Reed	799,720	0	0	For
MUTUAL FUND SERIES TRUST	785,423	0	0	For
SEI	778,152	0	0	For
Dimensional	757,205	0	0	For
INVESTMENT CO OF AMERICA	746,548	0	0	For
Russell Investments	706,504	0	0	For
Pacific Life	597,826	0	0	For
AQR	589,521	0	0	For
Invesco	492,262	0	0	For
HOMESTEAD FUNDS INC	483,484	0	0	For
Thrivent	464,381	0	0	For
JPMorgan	451,921	0	0	For
AB EQUITY INCOME FUND INC	365,672	0	0	For

Showing the 25 largest of 93 asset managers. See all 93 in the interactive database.

21. AUTHORIZE THE BOARD TO ALLOT SHARES.

CAPITAL STRUCTURE

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 93 asset managers below cast 99.9% of the shares they voted on this item FOR (123,586,394 for, 64,194 against).

FOR: 123,586,394 (99.9%)AGAINST: 64,194 (0.1%)ABSTAIN: 1 (0.0%)NOT VOTED: 151 (0.0%)

Largest asset managers voting on “AUTHORIZE THE BOARD TO ALLOT SHARES.” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	36,894,533	5	1	For
Fidelity	36,506,273	0	0	For
Morgan Stanley	10,461,310	0	0	For
BlackRock	6,959,499	0	0	For
Victory Capital	6,381,179	0	0	For
Charles Schwab	3,109,467	0	0	For
Transamerica	2,430,209	0	0	For
Advisor Managed Portfolios	2,270,000	0	0	For
Brighthouse	1,979,775	40,943	0	For
Capital Group	1,912,455	0	0	For
First Trust	1,013,486	0	0	For
TIAA	837,390	0	0	For
Waddell & Reed	799,720	0	0	For
MUTUAL FUND SERIES TRUST	785,423	0	0	For
SEI	778,152	0	0	For
Dimensional	757,205	0	0	For
INVESTMENT CO OF AMERICA	746,548	0	0	For
Russell Investments	706,504	0	0	For
Pacific Life	597,826	0	0	For
AQR	589,521	0	0	For
Invesco	492,262	0	0	For
HOMESTEAD FUNDS INC	483,484	0	0	For
Thrivent	464,381	0	0	For
JPMorgan	451,921	0	0	For
AB EQUITY INCOME FUND INC	365,672	0	0	For

Showing the 25 largest of 93 asset managers. See all 93 in the interactive database.

22. DIRECT THE CHAIRMAN, IF HE DETERMINES THAT THERE ARE INSUFFICIENT VOTES CAST IN FAVOR OF PROPOSAL 2 (BELOW), TO ADJOURN THE ANNUAL GENERAL MEETING AND SPECIAL MEETING TO SUCH TIME AND PLACE THAT HE, IN HIS ABSOLUTE DISCRETION, CONSIDERS FIT.

OTHER

Combines 2 wordings of this item as funds reported it.

99.7% fund support · no official result

FOR 99.6%

The 93 asset managers below cast 99.7% of the shares they voted on this item FOR (123,270,303 for, 339,343 against).

FOR: 123,270,303 (99.7%)AGAINST: 339,343 (0.3%)ABSTAIN: 40,943 (0.0%)NOT VOTED: 151 (0.0%)

Largest asset managers voting on “DIRECT THE CHAIRMAN, IF HE DETERMINES THAT THERE ARE INSUFFICIENT VOTES CAST IN FAVOR OF PROPOSAL 2 (BELOW), T” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	36,894,528	10	0	For
Fidelity	36,506,273	0	0	For
Morgan Stanley	10,461,310	0	0	For
BlackRock	6,959,499	0	0	For
Victory Capital	6,381,179	0	0	For
Charles Schwab	3,109,467	0	0	For
Transamerica	2,430,209	0	0	For
Advisor Managed Portfolios	2,270,000	0	0	For
Brighthouse	1,979,775	0	40,943	For
Capital Group	1,912,455	0	0	For
First Trust	1,013,486	0	0	For
TIAA	837,390	0	0	For
Waddell & Reed	799,720	0	0	For
MUTUAL FUND SERIES TRUST	785,423	0	0	For
SEI	778,152	0	0	For
Dimensional	757,205	0	0	For
INVESTMENT CO OF AMERICA	746,548	0	0	For
Russell Investments	706,504	0	0	For
Pacific Life	597,826	0	0	For
AQR	589,521	0	0	For
Invesco	492,262	0	0	For
HOMESTEAD FUNDS INC	483,484	0	0	For
Thrivent	464,381	0	0	For
JPMorgan	451,921	0	0	For
AB EQUITY INCOME FUND INC	365,672	0	0	For

Showing the 25 largest of 93 asset managers. See all 93 in the interactive database.

23. RE-APPOINT ERNST & YOUNG AS OUR U.K. STATUTORY AUDITOR, TO HOLD OFFICE UNTIL THE CONCLUSION OF THE NEXT GENERAL MEETING AT WHICH THE U.K. ANNUAL REPORT AND ACCOUNTS ARE PRESENTED TO SHAREHOLDERS.

AUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 93 asset managers below cast 99.9% of the shares they voted on this item FOR (123,609,646 for, 0 against).

FOR: 123,609,646 (100.0%)AGAINST: 0 (0.0%)ABSTAIN: 40,943 (0.0%)NOT VOTED: 151 (0.0%)

Largest asset managers voting on “RE-APPOINT ERNST & YOUNG AS OUR U.K. STATUTORY AUDITOR, TO HOLD OFFICE UNTIL THE CONCLUSION OF THE NEXT GENERA” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	36,894,539	0	For
Fidelity	36,506,273	0	For
Morgan Stanley	10,461,310	0	For
BlackRock	6,959,499	0	For
Victory Capital	6,381,179	0	For
Charles Schwab	3,109,467	0	For
Transamerica	2,430,209	0	For
Advisor Managed Portfolios	2,270,000	0	For
Brighthouse	1,979,775	40,943	For
Capital Group	1,912,455	0	For
First Trust	1,013,486	0	For
TIAA	837,390	0	For
Waddell & Reed	799,720	0	For
MUTUAL FUND SERIES TRUST	785,423	0	For
SEI	778,152	0	For
Dimensional	757,205	0	For
INVESTMENT CO OF AMERICA	746,548	0	For
Russell Investments	706,504	0	For
Pacific Life	597,826	0	For
AQR	589,521	0	For
Invesco	492,262	0	For
HOMESTEAD FUNDS INC	483,484	0	For
Thrivent	464,381	0	For
JPMorgan	451,921	0	For
AB EQUITY INCOME FUND INC	365,672	0	For

Showing the 25 largest of 93 asset managers. See all 93 in the interactive database.

24. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

91% fund support · no official result

FOR 91%9%

The 15 asset managers below cast 91% of the shares they voted on this item FOR (8,555,403 for, 829,668 against).

FOR: 8,555,403 (91.2%)AGAINST: 829,668 (8.8%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Vote
ADAGE CAPITAL PARTNERS GP, L.L.C.	6,050,000	0	For
BlackRock	1,008,481	0	For
JPMorgan	675,317	0	For
STOREBRAND ASSET MANAGEMENT AS	645,405	0	For
APG Asset Management US Inc.	0	503,176	Against
Desjardins Global Asset Management Inc.	0	257,576	Against
TD ASSET MANAGEMENT INC	83,325	0	For
Regime de rentes du Mouvement Desjardins	0	67,647	Against
AGF Investments Trust	46,200	0	For
Uniplan Investment Counsel, Inc.	24,362	0	For
GuideStone	15,174	0	For
TOBAM	7,106	0	For
LOUISBOURG INVESTMENTS INC.	0	905	Against
Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma	0	364	Against
Convergence Investment Partners, LLC	33	0	For

25. Advisory Vote on Golden Parachutes

SECTION 14A SAY-ON-PAY VOTES

99.9% fund support · no official result

FOR 99.9%

The 13 asset managers below cast 99.9% of the shares they voted on this item FOR (8,466,891 for, 2,985 against).

FOR: 8,466,891 (100.0%)AGAINST: 2,985 (0.0%)NOT VOTED: 33 (0.0%)

Largest asset managers voting on “Advisory Vote on Golden Parachutes” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Vote
ADAGE CAPITAL PARTNERS GP, L.L.C.	6,050,000	0	For
BlackRock	1,005,496	2,985	For
JPMorgan	675,317	0	For
APG Asset Management US Inc.	503,176	0	For
TD ASSET MANAGEMENT INC	83,325	0	For
Regime de rentes du Mouvement Desjardins	67,647	0	For
AGF Investments Trust	46,200	0	For
GuideStone	15,174	0	For
Uniplan Investment Counsel, Inc.	12,181	0	For
TOBAM	7,106	0	For
LOUISBOURG INVESTMENTS INC.	905	0	For
Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma	364	0	For
Convergence Investment Partners, LLC	0	0	Not Voted

26. Approve Remuneration Report

SECTION 14A SAY-ON-PAY VOTESCOMPENSATION

76% fund support · no official result

FOR 76%AGAINST 24%

The 8 asset managers below cast 76% of the shares they voted on this item FOR (2,397,683 for, 760,752 against).

FOR: 2,397,683 (75.9%)AGAINST: 760,752 (24.1%)

Largest asset managers voting on “Approve Remuneration Report” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Vote
BlackRock	1,008,481	0	For
JPMorgan	675,317	0	For
STOREBRAND ASSET MANAGEMENT AS	645,405	0	For
APG Asset Management US Inc.	0	503,176	Against
Desjardins Global Asset Management Inc.	0	257,576	Against
AGF Investments Trust	46,200	0	For
GuideStone	15,174	0	For
TOBAM	7,106	0	For

27. APPROVE REMUNERATION POLICY

SECTION 14A SAY-ON-PAY VOTES

94% fund support · no official result

FOR 94%

The 5 asset managers below cast 94% of the shares they voted on this item FOR (1,082,036 for, 67,647 against).

FOR: 1,082,036 (94.1%)AGAINST: 67,647 (5.9%)

Largest asset managers voting on “APPROVE REMUNERATION POLICY” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Vote
BlackRock	1,008,481	0	For
Regime de rentes du Mouvement Desjardins	0	67,647	Against
AGF Investments Trust	46,200	0	For
GuideStone	15,174	0	For
Uniplan Investment Counsel, Inc.	12,181	0	For

28. 14A Executive Compensation

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (92,541 for, 0 against).

FOR: 92,541 (100.0%)

Largest asset managers voting on “14A Executive Compensation” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Vote
Inlet Private Wealth, LLC	91,090	For
Focus Partners Wealth	1,434	For
VOISARD ASSET MANAGEMENT GROUP, INC.	17	For

29. Accept Financial Statements and Statutory Reports

COMPENSATION

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (61,374 for, 0 against).

FOR: 61,374 (100.0%)

Largest asset managers voting on “Accept Financial Statements and Statutory Reports” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
AGF Investments Trust	46,200	0	0	0	For
GuideStone	15,174	0	0	0	For

30. Adjourn Meeting

COMPENSATION

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (61,374 for, 0 against).

FOR: 61,374 (100.0%)

Largest asset managers voting on “Adjourn Meeting” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
AGF Investments Trust	46,200	0	0	0	For
GuideStone	15,174	0	0	0	For

31. Approval of the Equity Compensation Plan

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (1,269 for, 0 against).

FOR: 1,269 (100.0%)

Largest asset managers voting on “Approval of the Equity Compensation Plan” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
LOUISBOURG INVESTMENTS INC.	905	0	0	0	For
Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma	364	0	0	0	For

32. Approve Acquisition

COMPENSATION

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (61,374 for, 0 against).

FOR: 61,374 (100.0%)

Largest asset managers voting on “Approve Acquisition” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
AGF Investments Trust	46,200	0	0	0	For
GuideStone	15,174	0	0	0	For

33. Approve Omnibus Stock Plan

AUDIT-RELATED

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (61,374 for, 0 against).

FOR: 61,374 (100.0%)

Largest asset managers voting on “Approve Omnibus Stock Plan” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
AGF Investments Trust	46,200	0	0	0	For
GuideStone	15,174	0	0	0	For

34. Authorize Issue of Equity

CAPITAL STRUCTURE

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (61,374 for, 0 against).

FOR: 61,374 (100.0%)

Largest asset managers voting on “Authorize Issue of Equity” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
AGF Investments Trust	46,200	0	0	0	For
GuideStone	15,174	0	0	0	For

35. Authorize Issue of Equity without Pre-emptive Rights

CAPITAL STRUCTUREMajority of the votes cast: yes

92% Majority: yes · of votes cast

FOR 92%8%

FOR: 406,273,297AGAINST: 33,785,707

The 2 asset managers below cast 100% of the shares they voted on this item FOR (61,374 for, 0 against).

FOR 100%

FOR: 61,374 (100.0%)

Largest asset managers voting on “Authorize Issue of Equity without Pre-emptive Rights” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
AGF Investments Trust	46,200	0	0	0	For
GuideStone	15,174	0	0	0	For

36. Authorize Share Repurchase Program

CAPITAL STRUCTURE

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (61,374 for, 0 against).

FOR: 61,374 (100.0%)

Largest asset managers voting on “Authorize Share Repurchase Program” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
AGF Investments Trust	46,200	0	0	0	For
GuideStone	15,174	0	0	0	For

37. Ratify Ernst & Young as U.K. Statutory Auditors

OTHERMajority of the votes cast: yes

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 493,521,988AGAINST: 116,396

The 2 asset managers below cast 100% of the shares they voted on this item FOR (61,374 for, 0 against).

FOR 100%

FOR: 61,374 (100.0%)

Largest asset managers voting on “Ratify Ernst & Young as U.K. Statutory Auditors” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
AGF Investments Trust	46,200	0	0	0	For
GuideStone	15,174	0	0	0	For

38. Remuneration Policy

SECTION 14A SAY-ON-PAY VOTES

0% fund support · no official result

AGAINST 100%

The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 1,269 against).

AGAINST: 1,269 (100.0%)

Largest asset managers voting on “Remuneration Policy” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
LOUISBOURG INVESTMENTS INC.	0	905	0	0	Against
Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma	0	364	0	0	Against

39. Remuneration Report

SECTION 14A SAY-ON-PAY VOTES

0% fund support · no official result

AGAINST 100%

The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 1,269 against).

AGAINST: 1,269 (100.0%)

Largest asset managers voting on “Remuneration Report” at ROYALTY PHARMA PLC, 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
LOUISBOURG INVESTMENTS INC.	0	905	0	0	Against
Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma	0	364	0	0	Against

Largest ROYALTY PHARMA PLC shareholders voting in 2024-2025

Ranked by the number of ROYALTY PHARMA PLC shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 435,480,000 shares outstanding at the time of that meeting.

Top ROYALTY PHARMA PLC shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	Fidelity	15.62%
2	Morgan Stanley	9.77%
3	Vanguard	8.88%
4	BlackRock	4.28%
5	Swedbank Robur Fonder AB	2.79%
6	Victory Capital	2.32%
7	VIKING GLOBAL INVESTORS LP	2.07%
8	GEODE CAPITAL MANAGEMENT, LLC	1.85%
9	State Street	1.69%
10	Charles Schwab	1.44%

Reported ROYALTY PHARMA PLC ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

ROYALTY PHARMA PLC beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
Legorreta G. Pablo	23.68%	13D
RPI US Partners 2019, LP	22.57%	DEF14A
FMR (Fidelity)	9.05%	13F
Morgan Stanley	8.93%	DEF14A
Vanguard Group	8.42%	13F
Capital International Investors	7.52%	DEF14A
FMR LLC	6.41%	DEF14A
BlackRock	5.64%	13F
R & H Trust Co. (Guernsey) Limited	5.56%	13D
General Atlantic, L.P.	3.27%	13G

Percentages above are of 435,480,000 shares outstanding, as reported by ROYALTY PHARMA PLC on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ROYALTY PHARMA PLC’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At ROYALTY PHARMA PLC's shareholder meeting held 2025-05-12, in the 2024-2025 proxy season, 441 asset managers reported how they voted in their SEC Form N-PX filings, covering 11,048 separate fund positions. Their filings are grouped here into 39 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — A non-binding advisory vote to approve executive compensation that may become payable in… — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ROYALTY PHARMA PLC's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission (filing date not recorded for this item).

ROYALTY PHARMA PLC proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.